Athira Pharma, Inc. , a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation.
Athira Pharma stock last closed at $1.92, up 0% from the previous day, and has decreased 30.18% in one year. It has underperformed other stocks in the Biotechnology industry by 0.08 percentage points. Athira Pharma stock is currently +44.36% from its 52-week low of $1.33, and -55.33% from its 52-week high of $4.30.
At the moment, there are 38.33M ATHA shares outstanding. The market cap of ATHA is $73.59M. In the last 24 hours, 164,711 ATHA shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy ATHA stock.
Based on our experience, eToro is the best place to buy stocks. Here's why:
Get $10 towards your stock purchase by signing up for an account with eToro today.
Open eToro AccountNow that you've picked your brokerage, you need to fill out some personal details so you are able to buy ATHA stock today.
Now that you have created your account on the best stock market app, your next step is to transfer the money for your investment:
Check out the video below to see the process of depositing funds into your new investment account.
After you have figured out the best place to buy Athira Pharma stock, it's very important to evaluate their stock prior to investing, so you can comprehend the risk as well as the upside.
WallStreetZen was designed to help everyday investors perform better fundamental analysis quickly.
You can view all of the due diligence checks on ATHA's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge ATHA's intrinsic value.
Using relative valuations methods:
You can access more valuation research on ATHA's stock here.
You can dig deeper into what analysts are saying on the Athira Pharma stock forecast page.
In the past 12 months, insiders at ATHA have bought more shares than they have sold.
Kevin Church, CHIEF SCIENTIFIC OFFICER of ATHA, was the latest ATHA insider to sell. They sold $7,018.92 worth of ATHA stock on Jan 5, 2024.
Learn more about who owns ATHA shares here.
No, Athira Pharma doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
You have two primary options:
Hit the Open button and your broker will place the order.
If you require additional help buying stocks on eToro, click the helpful video below:
Now that you own some ATHA shares, you'll want to stay up-to-date on your investment.
Make a watchlist to keep track of your ATHA stock.
To reiterate, here are the 6 steps for buying Athira Pharma stock:
If you need a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you want to get notifications regarding your investment in Athira Pharma, click the button below.